دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Addressing Disability in Cancer Survivors
Brick, Rachelle PhD, MSPH, OTR/L1Tonorezos, Emily S. MD, MPH1
doi : 10.1200/JCO.24.00479
2024, Volume 42 (19)
Restaging With Prostate-Specific Membrane Antigen Imaging in Metastatic Castration-Resistant Prostate Cancer: When Seeing More Is Detrimental to Care
Madan, Ravi A. MD1Yu, Evan Y. MD2Posadas, Edwin M. MD, FACP3Lee, Richard J. MD, PhD4Karzai, Fatima MD1Choyke, Peter L. MD, FACR5
doi : 10.1200/JCO.23.02727
Surveillance Imaging After Curative-Intent Treatment for Cancer: Benefits, Harms, and Evidence
Wilson, Brooke E. MBBS, MSc, FRACP3Link to author's ORCID page: Wilson, Brooke E. MBBS, MSc, FRACPWright, Kristin MD2Koven, Rachel BA, MSc2Booth, Christopher M. MD, FRCP2Link to author's ORCID page: Booth, Christopher M. MD, FRCP
doi : 10.1200/JCO.23.02475
Durable Responses With Mosunetuzumab in Relapsed/Refractory Indolent and Aggressive B-Cell Non-Hodgkin Lymphomas: Extended Follow-Up of a Phase I/II Study
Budde, Lihua E. MD1Assouline, Sarit MD, MSc2Sehn, Laurie H. MD3Schuster, Stephen J. MD4Yoon, Sung-Soo MD, PhD5Yoon, Dok Hyun MD, PhD6Matasar, Matthew J. MD7Bosch, Francesc MD, PhD8
doi : 10.1200/JCO.23.02329
Prevalence and Cancer-Specific Patterns of Functional Disability Among US Cancer Survivors, 2017-2022
Cao, Chao PhD, MPH1Link to author's ORCID page: Cao, Chao PhD, MPHYang, Lin PhD2Link to author's ORCID page: Yang, Lin PhDSchmitz, Kathryn H. PhD, MPH3Link to author's ORCID page: Schmitz, Kathryn H. PhD, MPHLigibel, Jennifer A. MD1Link to author's ORCID page: Ligibel, Jennifer A. MD
doi : 10.1200/JCO.23.02536
International Prognostic Score for Nodular Lymphocyte–Predominant Hodgkin Lymphoma
Borchmann, Peter...Fuchs, Michael...Hartmann, Sylvia...Eich, Hans Theodor...Lo, Andrea C....Skinnider, Brian...Rauf, M. Shahzad...Maghfoor, Irfan...Pinnix, Chelsea C....Milgrom, Sarah A...Vega, Francisco...Alomari, Mohammed...Collins, Graham P....Advani, Ranjana H....Metzger, Monika L
doi : 10.1200/JCO.23.01655
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
Bardia, Aditya MD, PhD1Link to author's ORCID page: Bardia, Aditya MD, PhDKrop, Ian E. MD, PhD3Link to author's ORCID page: Krop, Ian E. MD, PhDKogawa, Takahiro MD, PhD4Link to author's ORCID page: Kogawa, Takahiro MD, PhDJuric, Dejan MD1Link to author's ORCID page: Juric, Dejan MDTolcher, Anthony W. MD7Link to author's ORCID page: Tolcher, Anthony W. MDHamilton, Erika P. MD9Link to author's ORCID page: Hamilton, Erika P. MDMukohara, Toru MD, DMedSci10Link to author's ORCID page: Mukohara, Toru MD, DMedSciLisberg, Aaron MD11
doi : 10.1200/JCO.23.01909
Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials
Gallois, Claire MD1Shi, Qian PhD2Pederson, Levi D. PhD2André, Thierry PhD3Iveson, Timothy J. PhD4Sobrero, Alberto F. PhD5Alberts, Steven PhD6de Gramont, Aimery PhD7Meyerhardt, Jeffrey A. PhD8
doi : 10.1200/JCO.23.01326
Trans-Ancestral Genetic Risk Factors for Treatment-Related Type 2 Diabetes Mellitus in Survivors of Childhood Cancer
Im, Cindy PhD1Neupane, Achal PhD2Baedke, Jessica L. MS2Lenny, Brian MS2Delaney, Angela MD3Dixon, Stephanie B. MD4Chow, Eric J. MD5Mostoufi-Moab, Sogol MD6Yang, Tianzhong PhD7
doi : 10.1200/JCO.23.02281
RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer
Clingan, Philip...Hayes, Theresa...Underhill, Craig...Demey, Wim...Forget, Frederic...Lambrechts, Marc...Nackaerts, Kristiaan...André Franke, Fabio...Azambuja, Alan Arrieira...Guimaraes, Rodrigo...Mourao Dias, Josiane...Santos, Victor...Cezar Uchoa Junior, Bruno...Alves, Gustavo Vasconcelos...de Melo Sette, Claudia Vaz...Bi, Minghong...Cui, Jiuwei...Fang, Jian
doi : 10.1200/JCO.23.02110
Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma
Barker, Christopher A. MD1Dufault, Suzanne PhD2Link to author's ORCID page: Dufault, Suzanne PhDArron, Sarah T. MD, PhD3Link to author's ORCID page: Arron, Sarah T. MD, PhDHo, Alan L. MD, PhD4Link to author's ORCID page: Ho, Alan L. MD, PhDAlgazi, Alain P. MD5Link to author's ORCID page: Algazi, Alain P. MDDunn, Lara A. MD4Humphries, Audrey A. BS6Link to author's ORCID page: Humphries, Audrey A. BSHultman, Carter BS6Lian, Ming MD1Knott, P. Daniel MD7Yom, Sue S. MD, PhD7Link to author's ORCID page: Yom, Sue S. MD, PhD
doi : 10.1200/JCO.23.01708
Palliative Care for Patients With Cancer: ASCO Guideline Update
Sanders, Justin J. MD, MSc1Temin, Sarah MSPH2Ghoshal, Arun MBBS, MD, MRes3Alesi, Erin R. MD4Ali, Zipporah Vunoro MD5Chauhan, Cynthia MSW6Cleary, James F. MD7Epstein, Andrew S. MD8
doi : 10.1200/JCO.24.00542
Does Duration of Adverse Events Matter in Cancer Clinical Trials?
Zhang, Sheng MDLi, Wenfeng MD
doi : 10.1200/JCO.23.02380
Investigating the Benefits of Collecting Low- and Moderate-Grade Adverse Events in Cancer Clinical Trials
Selukar, Subodh PhD
doi : 10.1200/JCO.24.00197
Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial
doi : 10.1200/JCO.24.00997
